NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
ROKIT America, Inc.

ROKIT America, Inc.

RKAMNASDAQ
filed

Issue Size

$25.00M

Price Range

$8.50 - $10.50

Shares

27.63M o/s · 2.63M offered

Sector

Consumer Staples

Filed

Apr 15, 2026

About

ROKIT America, Inc.

ROKIT America is committed to extending human healthspan and enhancing quality of life in an aging society through its proprietary Reverse Aging Product which is intended to support cellular health and aging-related biological processes at the molecular level, and its artificial intelligence hyper-personalized Organ Regeneration Platform, a proprietary technology developed by our parent company, ROKIT Healthcare, which is intended to provide regenerative medicine solutions in the Americas.

Since its founding in 2019, the Company has focused on the research and development of dietary supplements centered around β-Nicotinamide Mononucleotide (“NMN”). We have launched a range of NMN-based products into global markets, including the United States.

Our flagship product line, ROKIT AMERICA NMN, combines NMN with pterostilbene, a naturally occurring antioxidant.

ROKIT America, Inc. Overview

Ticker, listing venue and issuer profile

TickerRKAM
ExchangeNASDAQ
Statusfiled
SectorConsumer Staples
IndustryPackaged Foods
CurrencyUSD
CIK Code2087716
CUSIP--
ISIN--

Offer & Key Dates

Pricing terms and IPO milestones

Price Range$8.50 - $10.50
Offer Price--
Listing Price--
Current Price--
Shares Offered2.63M
Shares Outstanding27.63M
Offer Size$25.00M
Market Cap$262.50M
Filing DateApr 15, 2026
Priced Date--
Listed Date--

Valuation & Multiples

Key valuation ratios and metrics

P / E--
P / Book--
P / Sales--
EV / EBITDA--
EPS--
Revenue / Share (TTM)--
Revenue$7.43M
Net Income$1.59M

Financial Health

Balance sheet strength and liquidity

Total Debt$0.00
Total Assets$5.61M
Cash$183.69K
Free Cash Flow--
Current Ratio2.5
Quick Ratio2.14
Debt / Equity0
CapEx--

Profitability & Returns

Margins and return on capital

Gross Margin--
Operating Margin--
Net Margin--
Return on Equity57.86%
Return on Assets37.78%
ROIC57.86%
EBITDA--
Gross Profit$5.08M

Financial Highlights

Historical financial performance

SEC Filings

Official documents from SEC EDGAR

Company Info

Contact and headquarters details

HeadquartersUnited States
Founded2019
Phone(678) 861-0046
Address3435 Wilshire Blvd, Suite 2925Los Angeles, CA 90010United States

Leadership

Key executives and officers

SH

Seok Hwan You

Chief Executive Officer and Chairman of the Board of Directors

HY

Ha Young Kim

Chief Financial Officer and Director

SM

Seong Mo Jee

Chief Strategy Officer

MG

Min Gu Lee

Chief Medical Officer

WK

Won Kyung Choi

Chief Technology Officer

WY

Woo Young Kim

Chief Operation Officer

MK

Min Kyoung Choi

Chief Legal Officer

ROKIT America, Inc. IPO - FAQs

IPO (initial public offering) is the process through which a private company offers its shares to the public for the first time to raise equity capital from a broader base of public investors.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.